Skip to content

A randomised controlled trial on short term outcomes of using Fresh whole blood and Packed red blood cells for priming in cardiopulmonary bypass in neonatal and pediatric cardiac surgery

A RANDOMISED CONTROLLED TRIAL ON SHORT TERM OUTCOMES OF USING FRESH WHOLE BLOOD AND PACKED RED BLOOD CELLS FOR PRIMING IN CARDIOPULMONARY BYPASS IN NEONATAL AND PEDIATRIC CARDIAC SURGERY

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/053544
Enrollment
34
Registered
2023-06-05
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Q248- Other specified congenital malformations of heart

Interventions

Intervention1: Whole Blood Transfusion: Fresh Whole Blood Collected within 5 days will be transfused Control Intervention1: Packed Red Blood Cells: Packed Red Blood Cells will be transfused

Sponsors

Postgraduate Institute of Medical Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age less than 1 year 2.Undergoing elective cardiac surgery. 3.Requiring cardiopulmonary bypass during cardiac surgery. 4.Children of parents who provide consent for the study.

Exclusion criteria

Exclusion criteria: 1. Those children whose parents do not give consent for the study 2. Those who cannot be followed up during the study period. 3. Those children with pre-existing blood dyscrasias. 4. Emergency cases. 5. Patients not requiring CPB 6. Patient not fit to receive the blood product as per randomization due to clinical reasons 7. Recent antiplatelet or anticoagulation therapy 8. Patients undergoing complex surgery/repeat open heart surgery 9. Patients with rare blood groups and alloantibodies

Design outcomes

Secondary

MeasureTime frame
1. Mean transfusion requirement (ml/kg) 2. Mean length of stay in the intensive care unit 3.Mean length of stay in the hospital 4.Mean chest tube loss mL/kg 5. Difference in mean hemoglobin, coagulogram (PT, aPTT, INR, serum fibrinogen) and platelet count Timepoint: 4 hours 12 hours 24 hours

Primary

MeasureTime frame
Difference in mean donor exposures 24-hours post operativelyTimepoint: 24 hours

Countries

India

Contacts

Public ContactDr Sheetal Malhotra

Postgraduate Institute of Medical Education and Research

sheetalmalhotra50@gmail.com7087651723

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026